An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers.
Guyot B, Clément F, Drouet Y, Schmidt X, Lefort S, Delay E, Treilleux I, Foy JP, Jeanpierre S, Thomas E, Kielbassa J, Tonon L, Zhu HH, Saintigny P, Gao WQ, de la Fouchardiere A, Tirode F, Viari A, Blay JY, Maguer-Satta V.
Guyot B, et al. Among authors: maguer satta v.
Cancer Res Commun. 2023 Sep 29;3(9):1966-1980. doi: 10.1158/2767-9764.CRC-23-0196.
Cancer Res Commun. 2023.
PMID: 37707389
Free PMC article.